THRB and metabolic dysfunction-associated steatotic liver disease: Six articles were included in the study after performing a comprehensive search of various electronic databases for relevant data on the use of thyroid receptor agonists in the treatment of NASH using appropriate keywords and Medical Subject Headings MeSH - ‘Resmetirom’, ‘Thyroid Hormone Receptor Beta Agonists’, ‘Non-Alcoholic Steato-Hepatitis’, ‘Non-Alcoholic Fatty Liver Disease’ [15-20].